Portfolio company
Cristal Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops click chemistry reagents and nanoparticle delivery platforms for pharmaceutical and diagnostic partners in the life sciences industry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
Catena Biosciences
This deep-tech company develops protein conjugation technology and multi-payload conjugates to create targeted therapeutics for patients with oncology and autoimmune diseases.
CATALYA
This company develops synthetic polymer platform technology to improve the solubility, stability and delivery of biopharmaceuticals for the pharmaceutical and biotechnology industries.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Leash Bio
This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.
PNAS Therapeutics
This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.
Creasallis
This biotech company develops a technology that improves the penetration of antibody-based drugs into solid tumours for pharmaceutical and biopharmaceutical organisations.
Breeze
This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.
